Table 2.
Pharmacological and surgical treatments.
| Treated |
Primary efficacy |
Relapses |
||||
|---|---|---|---|---|---|---|
| n | % | n | % | n | % | |
| Total number of patients | ||||||
| Overall | 173 | 123 | 71.1 | 37 | 21.4 | |
| Type 1 AIP§ | 106 | 61.3 | 72 | 67.9 | 32 | 30.2 |
| Type 2 AIP§ | 48 | 27.7 | 37 | 77 | 3 | 6.25 |
| NOS-AIP§ | 19 | 11.0 | 14 | 7.6 | 2 | 10.5 |
| No treatment | ||||||
| Overall (on 173) | 24 | 13.9 | 0 | 0 | 1 | 4.2 |
| Type 1 AIP§ | 13 | 12.3 | 0 | 0 | 1 | 7.7 |
| Type 2 AIP§ | 8 | 16.7 | 0 | 0 | 0 | 0 |
| NOS-AIP§ | 3 | 15.7 | 0 | 0 | 0 | 0 |
| Surgery | ||||||
| Overall (on 173) | 15 | 8.6 | 0 | 0 | 1 | 7.1 |
| Type 1 AIP§ | 13 | 12.2 | 0 | 0 | 1 | 8.3 |
| Type 2 AIP§ | 2 | 4.2 | 0 | 0 | 0 | 0 |
| NOS-AIP§ | 0 | 0 | 0 | 0 | 0 | 0 |
| Surgery + Steroid | ||||||
| Overall (on 173) | 4 | 2.3 | 3 | 75 | 1 | 25 |
| Type 1 AIP§ | 3 | 2.8 | 2 | 66.7 | 1 | 33.3 |
| Type 2 AIP§ | 1 | 2 | 1 | 100 | 0 | 0 |
| NOS-AIP§ | 0 | 0 | 0 | 0 | 0 | 0 |
| Steroid | ||||||
| Overall* (on 173) | 122 | 70.5 | 113 | 91.9 | 32 | 26.0 |
| Type 1 AIP§ | 72 | 67.9 | 66 | 90.4 | 27 | 36.9 |
| Type 2 AIP§ | 34 | 70.8 | 33 | 97 | 3 | 8.8 |
| NOS-AIP§ | 16 | 84.2 | 14 | 87.5 | 2 | 12.5 |
| Azathioprine alone | ||||||
| Overall (on 173) | 8 | 4.6 | 7 | 87.5 | 2 | 25 |
| Type 1 AIP§ | 5 | 4.7 | 4 | 80 | 2 | 40 |
| Type 2 AIP§ | 3 | 6.25 | 3 | 100 | 0 | 0 |
| NOS-AIP§ | 0 | 0 | 0 | 0 | 0 | 0 |
§AIP: Autoimmune pancreatitis; °NOS: Not Otherwise Specified.